Allow your patients benefit the advantages of IMMUNOSCORE®
Improve the clinical management with precision medicine
Discover the Decision Impact Program (DIP)
and measure the impact of IMMUNOSCORE® on your daily practice in localized colon cancer
stage II patients
in high risk group
might be spared adjuvant chemotherapy
stage III patients
would benefit from adjustment of their treatment duration
DIP program is a commercial offer that will allow you to:
- Improve your precision oncology practice
- Corroborate the clinical data with IMMUNOSCORE® test in your own experience.
- Estimate the overall cost savings and medico-economic impact with optimized use of therapeutic.
- Improve patient’s quality of life.
- Enhance personalized approach with innovative precision oncology tool.
This program will generate real-world evidence to sustain precision medicine implementation in your center.